Early Clinical Experience with the Stealth Autoguide Cranial Robotic Guidance Platform for Stereotactic Brain Biopsy
Journal of Korean Neurosurgical Society · 01.05.2026 · 69 (3) · 472-481
DOI: 10.3340/jkns.2025.0183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Korean Neurosurgical Society, erschienen am 01.05.2026. Verfasst von Hye Seok Park und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
The aim of this study was to report the early clinical experience with stereotactic biopsy using the Medtronic Stealth Autoguide Cranial Robotic Guidance Platform, representing the first relevant clinical study in the Republic of Korea (ROK). We evaluated potential advantages and limitations related to workflow integration, instrument setup, procedural efficiency, accuracy, and safety.
Methods
A retrospective case series was conducted across three centers in the ROK. From April to July 2025, 17 consecutive patients underwent frameless stereotactic biopsy using the Stealth Autoguide system. Data on demographics, operative time, and complications were collected, and descriptive analyses were performed.
Results
Biopsy using the Stealth Autoguide System was successfully completed in 16 of 17 patients. The median operative time was 48 minutes (interquartile range, 33–64), and the median target alignment error was 0.4 mm (interquartile range, 0.3–0.6). One case required conversion to the conventional manual method due to targeting inaccuracy. Three cases of asymptomatic intracerebral hemorrhage occurred, including one at the tissue-harvest site and two with cortical hemorrhage, all of which were managed conservatively.
Conclusion
The Stealth Autoguide system facilitates a more efficient frameless stereotactic biopsy than conventional methods by reducing operative time, enhancing accuracy, and allowing for a smaller, muscle-sparing incision. However, some concerns remain, and further clinical validation is needed to define its optimal indications and safety profile.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Department of Neurosurgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Zitieren
APA
Park, H. S., Hwang, J. H., Nam, S. M., Ji, S. Y., Hwang, K., Kim, M. S., Han, J. H., Kim, Y. H., Park, C. K., Kim, C. Y., Byun, Y. H., & Kang, H. (2026). Early Clinical Experience with the Stealth Autoguide Cranial Robotic Guidance Platform for Stereotactic Brain Biopsy. Journal of Korean Neurosurgical Society, 69(3), 472-481. https://doi.org/10.3340/jkns.2025.0183
Vancouver
Park HS, Hwang JH, Nam SM, Ji SY, Hwang K, Kim MS, et al. Early Clinical Experience with the Stealth Autoguide Cranial Robotic Guidance Platform for Stereotactic Brain Biopsy. Journal of Korean Neurosurgical Society. 2026;69(3):472-481. doi:10.3340/jkns.2025.0183
BibTeX
@article{Park2026,
author = {Park, Hye Seok and Hwang, Jong Ha and Nam, Sun Mo and Ji, So Young and Hwang, Kihwan and Kim, Min-Sung and Han, Jung Ho and Kim, Yong Hwy and Park, Chul-Kee and Kim, Chae-Yong and Byun, Yoon Hwan and Kang, Ho},
title = {Early Clinical Experience with the Stealth Autoguide Cranial Robotic Guidance Platform for Stereotactic Brain Biopsy},
journal = {Journal of Korean Neurosurgical Society},
year = {2026},
volume = {69},
number = {3},
pages = {472--481},
doi = {10.3340/jkns.2025.0183}
}
EUVIMED